Tectonic Therapeutic (TECX) vs Zura Bio (ZURA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Tectonic Therapeutic (TECX) has outperformed Zura Bio (ZURA) over the past year, gaining 48.1% versus a loss of 4.8%. Tectonic Therapeutic is the larger company by market cap ($456.1 million vs $383.3 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | TECX | ZURA |
|---|---|---|
| Share price | $23.33 | $4.00 |
| Market cap | $456.09M | $383.32M |
| 1-day change | +2.55% | -3.15% |
| YTD return | +9.06% | -21.18% |
| 1-year return | +48.11% | -4.84% |
| 5-year return | -67.31% | — |
| EPS (TTM) | $-4.57 | $-1.12 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $39.53 | $7.44 |
| 52-week low | $15.45 | $3.15 |
| Distance from 52-week high | -40.98% | -46.24% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +228.46% | +350.00% |
| Average volume | 219.63K | 1.44M |
| Shares outstanding | 19.55M | 95.83M |
| Employees | 60 | 40 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TECX has outperformed ZURA by 53.0 percentage points over the past year.
About Tectonic Therapeutic
TECX stock →Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 60 employees
About Zura Bio
ZURA stock →Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for autoimmune and inflammatory disorders in the United States. The company develops Tibulizumab, a humanized IgG4 single-chain variable fragment bispecific antibody engineered to bind and neutralize both IL-17A and BAFF within a single therapeutic molecule, which is in Phase 2 clinical trial development.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 40 employees
TECX vs ZURA FAQ
Which is bigger, Tectonic Therapeutic or Zura Bio?
Tectonic Therapeutic (TECX) is larger, with a market capitalization of $456.09M compared with $383.32M for Zura Bio (ZURA).
Which stock has performed better over the past year, TECX or ZURA?
TECX returned +48.11% over the past 12 months, compared with -4.84% for ZURA (price return, excluding dividends). Past performance does not predict future results.
Are Tectonic Therapeutic and Zura Bio in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.